• Publications
  • Influence
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study
Summary.  Background: Osteoprotegerin (OPG) concentration in serum is associated with the presence and severity of atherosclerosis. Objective: To investigate the association between serumExpand
  • 72
  • 4
Atorvastatin and omega‐3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia
Summary.  Activation of factor (F)VII by tissue factor may represent a critical event during plaque rupture in acute coronary syndromes. Patients with combined hyperlipemia are at high risk forExpand
  • 34
  • 3
Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison
Plaque psoriasis has significant impact on patients’ quality of life. Topical therapy is considered the treatment mainstay for mild‐to‐moderate disease according to guidelines.Expand
  • 9
  • 1
Relation between serum osteoprotegerin and carotid intima media thickness in a general population – the Tromsø Study
Summary.  Background: Previous studies have reported conflicting results on the relation between serum osteoprotegerin (OPG) concentration and carotid intima media thickness (CIMT). Patients/methods:Expand
  • 43
  • 1
Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromsø study.
Letters to the Editor: Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromso study -
  • 12
  • 1
No evidence for the presence of tissue factor in high‐purity preparations of immunologically isolated eosinophils
Summary.  Background: To date, there is no unequivocal opinion on whether human eosinophils express tissue factor (TF). Therefore, we studied the expression of TF protein and activity in resting orExpand
  • 31
Association Between the Metabolic Syndrome, Its Individual Components, and Unprovoked Venous Thromboembolism: Results of a Patient-Level Meta-Analysis
Objective—The metabolic syndrome (MetS) may contribute to the pathogenesis of venous thromboembolism (VTE), but this association requires additional investigation. Approach and Results—We performed aExpand
  • 34
  • PDF
Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsø
D. D . R I BE I RO, * P . BUCCIARELL I , S . K . BR AEKKAN,§– W. M. L I J FER ING ,* S . M. PASSAMONTI , E . E . BR ODIN ,§– F . R . ROSENDAAL ,* I . MART INELL I and J . -B . HA NSEN §– *DepartmentExpand
  • 18
Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study
HbA1c, a marker of average plasma glucose level during the previous 8–12 weeks, is associated with the future risk of cardiovascular disease and all‐cause mortality.
  • 17